BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15196265)

  • 1. Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells.
    Radder CM; Beekhuizen H; Kanhai HH; Brand A
    Clin Exp Immunol; 2004 Jul; 137(1):216-22. PubMed ID: 15196265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia.
    Santoso S; Wihadmadyatami H; Bakchoul T; Werth S; Al-Fakhri N; Bein G; Kiefel V; Zhu J; Newman PJ; Bayat B; Sachs UJ
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1517-24. PubMed ID: 27283740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
    Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
    J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
    Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
    Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review.
    Tomac G; Gojčeta K; Grizelj R; Coen Herak D; Ostojić SB; Golubić Ćepulić B
    Transfus Med; 2022 Aug; 32(4):269-275. PubMed ID: 35730350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Anti-HPA-1a Antibodies Increase Endothelial Cell Apoptosis and Permeability.
    Dardik R; Salomon O
    J Vasc Res; 2021; 58(5):321-329. PubMed ID: 33975315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes.
    Bayat B; Traum A; Berghöfer H; Werth S; Zhu J; Bein G; Sachs UJ; Santoso S
    Thromb Haemost; 2019 Nov; 119(11):1807-1815. PubMed ID: 31587244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
    Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
    Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia.
    Ghevaert C; Campbell K; Walton J; Smith GA; Allen D; Williamson LM; Ouwehand WH; Ranasinghe E
    Transfusion; 2007 May; 47(5):901-10. PubMed ID: 17465957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia.
    Matusiak K; Patriquin CJ; Deniz S; Dzaja N; Smith JW; Wang G; Nazy I; Kelton JG; Arnold DM
    Transfusion; 2022 Nov; 62(11):2213-2222. PubMed ID: 36239096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HPA-1a-mediated platelet phagocytosis by monocytes in vitro and its inhibition by Fc gamma receptor (FcgammaR) reactive reagents.
    Wiener E; Abeyakoon O; Benchetrit G; Lyall M; Keler T; Rodeck CH
    Eur J Haematol; 2003 Feb; 70(2):67-74. PubMed ID: 12581186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study.
    Refsum E; Håkansson S; Mörtberg A; Wikman A; Westgren M
    Transfusion; 2018 Jan; 58(1):223-231. PubMed ID: 29119564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.
    Kjeldsen-Kragh J; Ni H; Skogen B
    Curr Opin Hematol; 2012 Nov; 19(6):469-74. PubMed ID: 22954726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro culture of colony forming unit-megakaryocyte (CFU-MK) in fetal alloimmune thrombocytopenia.
    Warwick RM; Vaughan J; Murray N; Lubenko A; Roberts I
    Br J Haematol; 1994 Dec; 88(4):874-7. PubMed ID: 7819112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study.
    Kjær M; Tiller H; Heide G; Kjeldsen-Kragh J; Skogen B; Husebekk A
    PLoS One; 2017; 12(8):e0182957. PubMed ID: 28837581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does anti-HPA-1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?
    McKelvy M; Tyagi S; Haar EV; Lakkaraja M; Tomy T; Corke S; Palmer T; Rottenstreich A; Kapur R; Zhi H; Newman D; Scatz-Siemers N; Bussel J
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30835. PubMed ID: 38212881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal alloimmune thrombocytopenia: antenatal management.
    Silver RM; Porter TF; Branch DW; Esplin MS; Scott JR
    Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.
    Lieberman L; Greinacher A; Murphy MF; Bussel J; Bakchoul T; Corke S; Kjaer M; Kjeldsen-Kragh J; Bertrand G; Oepkes D; Baker JM; Hume H; Massey E; Kaplan C; Arnold DM; Baidya S; Ryan G; Savoia H; Landry D; Shehata N;
    Br J Haematol; 2019 May; 185(3):549-562. PubMed ID: 30828796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
    Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
    Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.